Concepedia

H.E. Wander

HW

Statistics

Publications

5

Citations

230

H-Index

5

Active since

1986

Affiliations

University of Göttingen(Current)

H.E. Wander is an author at University of Göttingen specializing in pharmacology, oncology, and medicine.

Publications per year

1986–2009

5

Publications

5

Recombinant interferon alfa-2a with or without vinblastine in metastatic renal cell carcinoma: Results of a European multi-center phase III study

Sophie D. Fosså, Giovanni Martinelli, Ulrich Otto et al. · Annals of Oncology · 1992 · 127 citations

, , +15

Aminoglutethimide in the treatment of premenopausal patients with metastatic breast cancer

H.E. Wander, H.Ch. Blossey, G. A. Nagel · European Journal of Cancer and Clinical Oncology · 1986 · 42 citations

, , +11

A phase II study in advanced breast cancer: ZD1694 ('Tomudex') a novel direct and specific thymidylate synthase inhibitor

Ian Smith, Amanda C. Jones, M. Spielmann et al. · British Journal of Cancer · 1996 · 35 citations · Full text

, , +7

Fluorouracil versus folinic acid/fluorouracil in advanced colorectal cancer--preliminary results of a randomized trial.

B. Steinke, E. Günther, W. D. Hirschmann et al. · PubMed · 1992 · 15 citations

, , +7

Phase-II Trial of Oral Idarubicin (4-Demethoxydaunorubicin) in Advanced Breast Cancer

H.E. Wander, Dirk Meyer, P. Schuff‐Werner et al. · Onkologie · 2009 · 11 citations

, , +8

1–5 of 5